Cited 9 time in
A bioactive microparticle-loaded osteogenically enhanced bioprinted scaffold that permits sustained release of BMP-2
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Seok, Ji Min | - |
| dc.contributor.author | Kim, Min Ji | - |
| dc.contributor.author | Park, Jin Ho | - |
| dc.contributor.author | Kim, Dahong | - |
| dc.contributor.author | Lee, Dongjin | - |
| dc.contributor.author | Yeo, Seon Ju | - |
| dc.contributor.author | Lee, Jun Hee | - |
| dc.contributor.author | Lee, Kangwon | - |
| dc.contributor.author | Byun, June-Ho | - |
| dc.contributor.author | Oh, Se Heang | - |
| dc.contributor.author | Park, Su A | - |
| dc.date.accessioned | 2023-06-28T08:40:30Z | - |
| dc.date.available | 2023-06-28T08:40:30Z | - |
| dc.date.issued | 2023-08 | - |
| dc.identifier.issn | 2590-0064 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/59686 | - |
| dc.description.abstract | Extrusion-based bioprinting technology is widely used for tissue regeneration and reconstruction. However, the method that uses only hydrogel as the bioink base material exhibits limited biofunctional properties and needs improvement to achieve the desired tissue regeneration. In this study, we present a three-dimensionally printed bioactive microparticle-loaded scaffold for use in bone regeneration applications. The unique structure of the microparticles provided sustained release of growth factor for > 4 weeks without the use of toxic or harmful substances. Before and after printing, the optimal particle ratio in the bioink for cell viability demonstrated a survival rate of ≥ 85% over 7 days. Notably, osteogenic differentiation and mineralization—mediated by human periosteum-derived cells in scaffolds with bioactive microparticles—increased over a 2-week interval. Here, we present an alternative bioprinting strategy that uses the sustained release of bioactive microparticles to improve biofunctional properties in a manner that is acceptable for clinical bone regeneration applications. © 2023 The Author(s) | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier B.V. | - |
| dc.title | A bioactive microparticle-loaded osteogenically enhanced bioprinted scaffold that permits sustained release of BMP-2 | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.mtbio.2023.100685 | - |
| dc.identifier.scopusid | 2-s2.0-85162181926 | - |
| dc.identifier.wosid | 001025817500001 | - |
| dc.identifier.bibliographicCitation | Materials Today Bio, v.21 | - |
| dc.citation.title | Materials Today Bio | - |
| dc.citation.volume | 21 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Engineering | - |
| dc.relation.journalResearchArea | Materials Science | - |
| dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
| dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
| dc.subject.keywordPlus | GROWTH-FACTOR DELIVERY | - |
| dc.subject.keywordPlus | ALGINATE | - |
| dc.subject.keywordPlus | BIOINK | - |
| dc.subject.keywordPlus | DRUG | - |
| dc.subject.keywordPlus | NANOPARTICLES | - |
| dc.subject.keywordPlus | HYDROGEL | - |
| dc.subject.keywordAuthor | Bioprinting | - |
| dc.subject.keywordAuthor | BMP-2 | - |
| dc.subject.keywordAuthor | Microparticle | - |
| dc.subject.keywordAuthor | Scaffold | - |
| dc.subject.keywordAuthor | Sustained release | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
